Amber Implants recently closed a $10 million series A financing round, the spinal implant company said Jan. 19.
The company said it will use the funds to further validate its vertebral body augmentation system, VCFix, through testing and clinical studies. The system earned a breakthrough device designation from the FDA in September.
VCFix is a 3D-printed vertebral fracture implant that stimulates bone ingrowth and stability without bone cement.
Centinel Spine, a global medical device company, reported a 33% increase in year-over-year revenue during the first quarter of 2025. …
Aurora Spine reported $17.6 million in revenue during fiscal year 2024, an increase of more than 20% over the previous…
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and…
Comments are closed.